Abstract
Background: Prisoner health is a major global concern, with prisoners often facing limited access to health care and enduring chronic diseases, infectious diseases, and poor mental health due to unsafe prison environments, unhygienic living conditions, and inadequate medical resources. In Taiwan, prison health is increasingly an issue, particularly concerning urinary diseases such as urinary tract infections. Limited access to health care and unsanitary conditions exacerbate these problems. Urinary disease epidemiology varies by sex and age, yet studies in Asia are scarce, and comprehensive data on urinary diseases in Taiwanese prisons remain limited.
Objective: This study aimed to investigate the prevalence of urinary diseases among Taiwanese prisoners and explore the differences in disease prevalence between men and women, as well as across different age groups.
Methods: This study used data on prisoners from the National Health Insurance Research Database covering the period from January 1 to December 31, 2013. Prisoners covered by National Health Insurance who were diagnosed with urinary diseases, identified by ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) codes 580‐599 based on their medical records, and had more than one medical visit to ambulatory care or inpatient services were included. Sex- and age-stratified analyses were conducted to determine the differences in the prevalence of urinary diseases.
Results: We examined 83,048 prisoners, including 2998 with urinary diseases. The overall prevalence of urinary system diseases among prisoners was 3.61% (n=2998; n=574, 6.64% in men and n=2424, 3.26% in women). The prevalence rate in men was significantly lower than that in women (prevalence ratio: 0.46, P<.001). In age-stratified analysis, the prevalence rate among prisoners aged >40 years was 4.5% (n=1815), compared to 2.77% (n=1183) in prisoners aged ≤40 years. Prisoners aged >40 years had a higher prevalence (prevalence ratio: 1.69, P<.001). Other disorders of the urethra and urinary tract (ICD-9-CM: 599), including urinary tract infection, urinary obstruction, and hematuria, were the most prevalent diseases of the urethra and urinary tract across age and sex groups. Women and older prisoners had a higher prevalence of most urinary tract diseases. There were no significant sex-specific differences in adjusted prevalence ratios for acute glomerulonephritis, nephrotic syndrome, kidney infections, urethritis (nonsexually transmitted), or urethral syndrome. However, based on the age-specific adjusted prevalence ratio analysis, cystitis was more prevalent among younger prisoners (prevalence ratio: 0.69, P=.004).
Conclusions: Urinary system infections and inflammation are common in prisons. Our findings advocate for policy reforms aimed at improving health care accessibility in prisons, with a particular focus on the needs of high-risk groups such as women and older prisoners. Further research linking claims data with prisoner information is crucial to providing more comprehensive medical services and achieving health equity.
doi:10.2196/60136
Keywords
Introduction
Background
Inmate health is a major global concern [
]. Prisoners often lack access to health care and face injustices due to unsafe prison environments, unhygienic living conditions, and a lack of medical resources. All of these factors correlate with the high prevalence of chronic diseases, infectious diseases, and poor mental health in prisoners [ - ]. A burgeon of literature suggests a negative relationship between incarceration and health [ - ]. These health inequalities are associated with potential additional medical expenditure. Prison overcrowding correlates significantly with the spread of infectious and communicable diseases [ ]. The close living quarters and limited access to health care in prisons can result in rapid disease transmission among inmates and into the community upon their release [ ]. This emphasizes the importance of implementing effective public health measures in correctional facilities to minimize the impact of infectious diseases on both inmates and the general population. Moreover, incarcerated populations may be significantly exposed to extreme temperatures, as indicated by existing cases [ ]. Both low and high temperatures are associated with emergency department visits for renal and urinary diseases, with heat having a stronger impact than cold. Furthermore, emergency department visits tend to decrease on days with low temperatures [ ].Urinary Diseases
Urinary tract infections (UTIs) are among the most prevalent types of infectious diseases worldwide [
, ]. Despite their widespread occurrence, they are not currently classified as mandatory reportable conditions. The true frequency and burden of UTIs are likely underestimated due to a lack of comprehensive data on their prevalence and impact [ - ]. UTIs not only have an impact on individuals but also pose a significant public health concern. The overuse and misuse of antibiotics to treat UTIs contribute to antimicrobial resistance, making effective management more difficult. Moreover, untreated UTIs can potentially lead to more serious complications, particularly in vulnerable populations such as older adults or individuals with compromised immune systems [ ]. Furthermore, a link has been discovered between early-stage chronic kidney disease (CKD) and higher health care costs over a 5-year period. Therefore, it is important to develop strategies to prevent CKD progression and reduce the associated health care expenses [ ].Understanding the differences in urinary disease epidemiology between men and women are crucial for providing sex-specific patient care. Evidence suggests that there are sex differences in the risk and outcomes of urinary disease, with mixed results depending on the cause [
, ]. Urinary disease is prevalent among individuals from disadvantaged socioeconomic backgrounds. These groups are also disproportionately affected by incarceration, and face barriers in accessing health care. Little is known about the status of urological diseases in imprisoned individuals. Some evidence suggests that the prevalence of self-reported kidney problems among incarcerated individuals varies across correctional settings; however, nuanced data characterizing urological disease trends in this population are lacking [ ].The health of prisoners in Taiwan has become a focal point, and in the past decade, the focus has shifted from solely addressing issues related to HIV, hepatitis, and other notifiable diseases to encompassing a broader range of illnesses. Data on the prevalence of diseases including oral and eye diseases are also available [
, ].To eliminate inequalities in prisoner health, it is important to understand the specific status of each disease. This study aimed to explore the health status of Taiwanese prisoners with urinary diseases. We evaluated the prevalence of urinary diseases across different sex and age groups among prisoners in Taiwan to comprehensively review their health status, improve the identification of urinary diseases by health care professionals, and provide a basis for health policy decisions.
Methods
Data Source
This cross-sectional study was conducted to determine the prevalence of urinary diseases in Taiwanese prisoners, and to clarify differences in sex and age. In Taiwan, the Ministry of Health and Welfare supervises the medical care of prisoners, ensuring they receive a comprehensive initial assessment of their mental and physical health status—including medical history, current status, and past medical history—by medical professionals upon entry. All medical services accessed by prisoners are covered by the National Health Insurance program. This program in Taiwan aims to ensure the right to access health care for all individuals, regardless of their financial status, education, or race. Since March 1, 1995, the compulsory social insurance system has consisted of public and private insurance, and it covers 23,355,508 (>99%) of the Taiwanese population. The Taiwan National Health Insurance Research Database (NHIRD) records the claims data, including inpatient and outpatient records, investigations, and treatment of insured individuals [
]. The data used in this study were extracted directly from the database to prevent underestimation and bias of the actual prevalence that could occur through self-reported data obtained from incarcerated individuals.This study used the datasets of ambulatory care expenditures by visits and datasets of inpatient expenditures by admissions from the NHIRD. We have previously investigated the prevalence of oral health and skin diseases among prison inmates in Taiwan [
, ].Study Design
We extracted claims data for all inmates from January 1 to December 31, 2013, including 1,122,922 person-times of outpatient data and 15,383 person-times of hospitalization data. We combined the medical records of both outpatient and inpatient visits and summarized the data for each individual. In total, this study includes 83,048 inmates. The ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) codes were used to define the diagnosis of urinary diseases [
]. Participants were identified as inmates with urinary diseases, indicated by ICD-9 codes 580‐599 in their medical records, and who had more than one medical visit.Ethical Considerations
This study was conducted using data from the National Health Research Insurance Database and was approved by the Institutional Review Board Research Ethics Committee of Taizhou Hospital of Zhejiang Province (TZH-IRB: K20240836). The National Health Research Institutes encrypted the names of patients, medical care providers, and institutions, replacing the identity numbers of all insured persons with alternative unique numbers to protect their privacy. All applications for National Health Research Insurance Database access are reviewed by peer experts to ensure the rationality of their use. Researchers must comply with Taiwan’s Computer-Processed Personal Data Protection Law and related regulations when accessing the data, and they must sign an agreement declaring that they will not attempt to retrieve information about patients or medical care providers.
Statistical Analysis
All analyses were performed using SAS (version 9.4; SAS Institute Inc). Prevalence data are expressed as numbers and percentages. The chi-square test and Fisher exact test were used to assess sex- and age-group differences in the disease percentages, and the prevalence ratio was calculated using the GENMOD procedure.
Results
Demographics Outcomes
This study included data from 83,048 prisoners (
), comprising 74,405 (89.59%) men and 8643 (10.41%) women. As shown in , 2424 male inmates were identified as having urinary system diseases, with an average age of 46.46 (SD 13.07) years and an average of 28.03 (SD 22.08) medical service visits per year. Among female inmates, 574 had urinary diseases, with an average age of 39.25 (SD 12.37) years and an average of 32.79 (SD 23.51) times per year using medical services, including outpatient and emergency services as well as hospitalization.Total | Diseases of urinary system | |||
Women (n=8643) | Men (n=74,405) | Women (n=574) | Men (n=2424) | |
Age (years) | ||||
38.65 (11.79) | 41.50 (11.43) | 39.25 (12.37) | 46.46 (13.07) | |
2‐88 | 2‐103 | 2‐81 | 3‐97 | |
Medicine service times (a year) | ||||
18.17 (15.83) | 13.27 (13.16) | 32.79 (23.51) | 28.03 (22.08) | |
1‐228 | 1‐369 | 2‐228 | 2‐369 |
Prevalence of Urinary Diseases
The prevalence of urinary system disorders among the prisoners was 3.61% (n=2998; n=574, 6.64% and n=2424, 3.26% in women and men, respectively). Diseases with the highest prevalence were other disorders of the urethra and urinary tract (ICD-9-CM: 599), including UTI, urinary obstruction, and hematuria, which occurred in 4.65% (n=402) of women and 1.46% (n=1086) of men. The disease with the second highest prevalence differed by sex; it was cystitis (n=115, 1.33%) in women and calculus of the kidney and ureter (n=629, 0.85%) in men.
The significant sex differences in chronic renal failure (ICD-9-CM: 585), kidney infections (ICD-9-CM: 590), calculus of the kidney and ureter (ICD-9-CM: 592), cystitis (ICD-9-CM: 595), and other disorders of the urethra and urinary tract (ICD-9-CM: 599) are shown in (
).Women | Men | P value | ||||
n (%) | Age (years), mean (SD) | n (%) | Age (years), mean (SD) | |||
Total prisoners | 8643 (10.41) | 38.65 (11.79) | 74,405 (89.59) | 41.50 (11.43) | — | |
ICD9 | _580‐599: diseases of the urinary system574 (6.64) | 39.25 (12.37) | 2424 (3.26) | 46.46 (13.07) | <.001 | |
ICD9_580‐589: nephritis, nephrotic syndrome, and nephrosis | 32 (0.37) | 47.59 (11.03) | 564 (0.76) | 51.44 (12.78) | <.001 | |
ICD9_580: acute glomerulonephritis | 1 (0.01) | — | 5 (0.01) | 39.2 (12.91) | .36 | |
ICD9_581: nephrotic syndrome | 3 (0.03) | 51.67 (12.66) | 67 (0.09) | 43.81 (13.29) | .09 | |
ICD9_582: chronic glomerulonephritis | 7 (0.08) | 43.57 (11.59) | 45 (0.06) | 51.49 (13.88) | .47 | |
ICD9_583: nephritis and nephropathy, not specified as acute or chronic | 5 (0.06) | 44.2 (15.55) | 28 (0.04) | 53.54 (12.29) | .13 | |
ICD9_584: acute renal failure | 2 (0.02) | 46.5 (2.12) | 78 (0.1) | 48.67 (14.3) | .02 | |
ICD9_585: chronic renal failure | 17 (0.2) | 49.06 (10.54) | 330 (0.44) | 52.79 (11.65) | .001 | |
ICD9_586: renal failure, unspecified | 3 (0.03) | 53.67 (9.02) | 40 (0.05) | 52.7 (11.19) | .17 | |
ICD9_587: renal sclerosis, unspecified | 0 (0) | — | 1 (<0.01) | — | .90 | |
ICD9_588: disorders resulting from impaired renal function | 3 (0.03) | 43.67 (10.07) | 45 (0.06) | 55.89 (11.47) | .14 | |
ICD9_589: small kidney of unknown cause | 0 (0) | — | 0 (0) | — | — | |
ICD9_590‐599: other diseases of urinary system | 550 (6.36) | 38.8 (12.22) | 1922 (2.58) | 45.25 (12.94) | <.001 | |
ICD9_590: infections of kidney | 45 (0.52) | 37.33 (13.23) | 58 (0.08) | 43.88 (10.39) | <.001 | |
ICD9_591: hydronephrosis | 12 (0.14) | 40.17 (8.45) | 168 (0.23) | 44.93 (10.9) | .10 | |
ICD9_592: calculus of kidney and ureter | 39 (0.45) | 43.85 (10.41) | 629 (0.85) | 45.65 (10.68) | <.001 | |
ICD9_593: other disorders of kidney and ureter | 10 (0.12) | 41.4 (12.32) | 56 (0.08) | 50.54 (14.38) | .21 | |
ICD9_594: calculus of lower urinary tract | 2 (0.02) | 53.5 (4.95) | 39 (0.05) | 49.33 (13.66) | .12 | |
ICD9_595: cystitis | 115 (1.33) | 37.76 (12.23) | 143 (0.19) | 38.9 (11.4) | <.001 | |
ICD9_596: other disorders of bladder | 16 (0.19) | 36.75 (12.8) | 171 (0.23) | 45.46 (14.41) | .41 | |
ICD9_597: urethritis, not sexually transmitted, and urethral syndrome | 10 (0.12) | 41.6 (12.37) | 63 (0.08) | 39.78 (12.6) | .36 | |
ICD9_598: urethral stricture | 0 (0) | — | 16 (0.02) | 51.44 (14.91) | — | |
ICD9_599: other disorders of urethra and urinary tract | 402 (4.65) | 38.92 (12.42) | 1086 (1.46) | 45.37 (13.61) | <.001 |
aICD9: International Classification of Diseases, Ninth Revision.
bNot applicable.
Age-specific prevalence rates are shown in
. There were significant differences in the prevalences of most disease classifications except for acute glomerulonephritis (ICD-9-CM: 580), nephrotic syndrome (ICD-9-CM: 581), renal sclerosis (ICD-9-CM: 587), hydronephrosis (ICD-9-CM: 591), and urethritis (not sexually transmitted), and urethral syndrome (ICD-9-CM: 597). In prisoners aged ≤40 years, three of the most common diseases were other disorders of the urethra and urinary tract (n=665, 1.56%), calculus of the kidney and ureter (n=223, 0.52%), and cystitis (n=165, 0.39%). Among men, the top three diseases were other disorders of the urethra and urinary tract (n=823, 2.04%), calculus of the kidney and ureter (n=445, 1.10%), and chronic renal failure (n=287, 0.71%).Aged ≤40 years | Aged >40 years | P value | ||||
n (%) | Age (years), mean (SD) | n (%) | Age (years), mean (SD) | |||
Total prisoners | 42,684 (51.4) | 32.30 (6.16) | 40,364 (48.6) | 50.62 (7.71) | — | |
ICD9 | _580‐599: diseases of the urinary system1183 (2.77) | 32.34 (6.19) | 1815 (4.5) | 53.38 (9.49) | <.001 | |
ICD9_580‐589: nephritis, nephrotic syndrome, and nephrosis | 135 (0.32) | 34.39 (4.95) | 461 (1.14) | 56.16 (9.72) | <.001 | |
ICD9_580: acute glomerulonephritis | 4 (0.01) | 34.00 (6.48) | 2 (<0.01) | 58.50 (2.12) | .25 | |
ICD9_581: nephrotic syndrome | 35 (0.08) | 32.91 (4.81) | 35 (0.09) | 55.37 (8.65) | .82 | |
ICD9_582: chronic glomerulonephritis | 15 (0.04) | 35.00 (4.72) | 37 (0.09) | 56.68 (10.97) | .001 | |
ICD9_583: nephritis and nephropathy, not specified as acute or chronic | 7 (0.02) | 33.43 (4.72) | 26 (0.06) | 57.15 (9.33) | .001 | |
ICD9_584: acute renal failure | 24 (0.06) | 33.13 (5.14) | 56 (0.14) | 55.25 (11.21) | .001 | |
ICD9_585: chronic renal failure | 60 (0.14) | 35.23 (4.83) | 287 (0.71) | 56.24 (9.04) | <.001 | |
ICD9_586: renal failure, unspecified | 6 (0.01) | 36.33 (3.67) | 37 (0.09) | 55.43 (9.28) | <.001 | |
ICD9_587: renal sclerosis, unspecified | 0 (0) | — | 1 (<0.01) | — | .49 | |
ICD9_588: disorders resulting from impaired renal function | 7 (0.02) | 37.57 (2.43) | 41 (0.1) | 58.12 (9.82) | <.001 | |
ICD9_589: small kidney of unknown cause | 0 (0) | — | 0 (0) | — | — | |
ICD9_590‐599: other diseases of urinary system | 1065 (2.5) | 32.12 (6.27) | 1407 (3.49) | 52.67 (9.38) | <.001 | |
ICD9_590: infections of kidney | 50 (0.12) | 31.16 (7.94) | 53 (0.13) | 50.32 (6.80) | .56 | |
ICD9_591: hydronephrosis | 71 (0.17) | 34.69 (4.04) | 109 (0.27) | 51.07 (8.72) | .001 | |
ICD9_592: calculus of kidney and ureter | 223 (0.52) | 34.69 (4.61) | 445 (1.1) | 50.99 (8.44) | <.001 | |
ICD9_593: other disorders of kidney and ureter | 19 (0.04) | 33.63 (5.56) | 47 (0.12) | 55.43 (11.85) | <.001 | |
ICD9_594: calculus of lower urinary tract | 12 (0.03) | 35.92 (1.88) | 29 (0.07) | 55.17 (11.89) | <.001 | |
ICD9_595: cystitis | 165 (0.39) | 31.12 (5.68) | 93 (0.23) | 51.28 (8.17) | <.001 | |
ICD9_596: other disorders of bladder | 80 (0.19) | 31.15 (4.77) | 107 (0.27) | 54.85 (10.37) | .02 | |
ICD9_597: urethritis, not sexually transmitted, and urethral syndrome | 44 (0.1) | 31.82 (5.37) | 29 (0.07) | 52.48 (9.53) | .13 | |
ICD9_598: urethral stricture | 3 (0.01) | 31.33 (3.79) | 13 (0.03) | 56.08 (12.30) | .009 | |
ICD9_599: other disorders of urethra and urinary tract | 665 (1.56) | 31.77 (6.59) | 823 (2.04) | 53.20 (9.70) | <.001 |
aICD9: International Classification of Diseases, Ninth Revision.
bNot applicable.
Age- and sex-specific adjusted prevalence ratios were calculated and are presented in
. Higher prevalence rates adjusted by age were observed in men for acute and chronic renal failure, calculus of the kidney and ureter, and other disorders of the urethra and urinary tract. In contrast, women had higher prevalences of kidney infection and cystitis compared to men. The sex-adjusted prevalence ratios were significantly >1 for most diseases, except for acute glomerulonephritis, nephrotic syndrome, kidney infections, urethritis (nonsexually transmitted), and urethral syndrome. Additionally, the prevalence of cystitis was lower in inmates aged >40 years compared to that in younger individuals.n (%) | PRsex | Psex | PRage | Page | ||
ICD9 | _580‐599: diseases of the urinary system2998 (3.61) | 0.46 | <.01 | 1.69 | <.001 | |
ICD9_580‐589: nephritis, nephrotic syndrome, and nephrosis | 596 (0.72) | 1.8 | <.01 | 3.54 | <.001 | |
ICD9_580: acute glomerulonephritis | 6 (0.01) | 0.62 | .66 | 0.54 | .48 | |
ICD9_581: nephrotic syndrome | 70 (0.08) | 2.59 | .11 | 1.03 | .90 | |
ICD9_582: chronic glomerulonephritis | 52 (0.06) | 0.67 | .33 | 2.66 | .002 | |
ICD9_583: nephritis and nephropathy, not specified as acute or chronic | 33 (0.04) | 0.57 | .24 | 4.04 | .001 | |
ICD9_584: acute renal failure | 80 (0.1) | 4.13 | .048 | 2.38 | <.001 | |
ICD9_585: chronic renal failure | 347 (0.42) | 1.93 | <.01 | 4.96 | <.001 | |
ICD9_586: renal failure, unspecified | 43 (0.05) | 1.31 | .66 | 6.46 | <.001 | |
ICD9_587: renal sclerosis, unspecified | 1 (<0.01) | — | — | — | — | |
ICD9_588: disorders resulting from impaired renal function | 48 (0.06) | 1.47 | .52 | 6.11 | <.001 | |
ICD9_589: small kidney of unknown cause | 0 (0) | — | — | — | — | |
ICD9_590‐599: other diseases of urinary system | 2472 (2.98) | 0.39 | <.01 | 1.47 | <.001 | |
ICD9_590: infections of kidney | 103 (0.12) | 0.15 | <.01 | 1.30 | .19 | |
ICD9_591: hydronephrosis | 180 (0.22) | 1.55 | .15 | 1.69 | .002 | |
ICD9_592: calculus of kidney and ureter | 668 (0.8) | 1.73 | <.01 | 2.07 | <.001 | |
ICD9_593: other disorders of kidney and ureter | 66 (0.08) | 0.59 | .12 | 2.69 | <.001 | |
ICD9_594: calculus of lower urinary tract | 41 (0.05) | 2.06 | .32 | 2.50 | .008 | |
ICD9_595: cystitis | 258 (0.31) | 0.15 | <.01 | 0.69 | .004 | |
ICD9_596: other disorders of bladder | 187 (0.23) | 1.20 | .49 | 1.41 | .02 | |
ICD9_597: urethritis, not sexually transmitted, and urethral syndrome | 73 (0.09) | 0.76 | .42 | 0.71 | .15 | |
ICD9_598: urethral stricture | 16 (0.02) | — | — | 4.38 | .02 | |
ICD9_599: other disorders of urethra and urinary tract | 1488 (1.79) | 0.30 | <.01 | 1.41 | <.001 |
aPR: prevalence ratio.
bICD9: International Classification of Diseases, Ninth Revision.
cNot applicable.
Discussion
Principal Findings
The provision of adequate medical care for incarcerated individuals is not only a matter of basic human rights but also a public health concern. Ensuring access to necessary health care services and providing a healthy environment can help prevent the spread of infectious diseases within correctional facilities and the broader community, as well as reduce the consumption of medical resources. In addition, addressing prisoners’ health care needs can contribute to their successful reintegration into society. Therefore, we conducted an analysis to determine the prevalence of urinary diseases in Taiwanese prisons.
The results of this study showed that most diseases with high prevalence were related to infection and inflammation of the urinary tract. Approximately 3.6% of the inmates had urinary diseases, and their prevalence differed according to sex and age. To our knowledge, this is the first study to explore urinary system diseases in Taiwanese inmates.
The annual statistics showed that the prevalence of nephritis, nephrotic syndrome, and nephrosis in the Taiwanese general population was 2.32%, with 2.61% in men and 2.03% in women [
]. The community-based screening program also found a higher CKD prevalence in the general population than in prisons [ ]. This disparity might reflect that the use of medical services for urinary diseases in prisons differs from the actual prevalence, indicating that many prisoners do not receive appropriate medical care. Consequently, this may overestimate the health status and quality of life of prisoners with urinary diseases, indicating that their conditions could be worse than previously thought.Consistent with previous research, we found that infections and inflammation of the urinary system are more prevalent in women (women: n=574, 6.64%, men: n=2424, 3.26%), and that the prevalence increases with age (>40 years: n=1815, 4.5% and ≤40 years: n=1183, 2.77%). Biological sex (women or men) widely influences various immune responses, including immune responses to mucosal surface diseases. Sex hormones, sex chromosomes, sexual dimorphism, and sexual differences all affect an organism’s response to urological diseases such as bladder infections or cancer [
, ]. Women are more likely to experience urinary system diseases, particularly infections. We infer the following reasons based on previous literatures. Anatomical differences, such as the shorter female urethra and its proximity to the anus, make women more prone to UTIs [ ]. Additionally, pregnancy and menopause can increase the risk of urinary incontinence, pelvic organ prolapse, and other urinary system disorders [ , ]. Furthermore, the female reproductive system, including the uterus and ovaries, can affect the urinary system and contribute to the development of diseases [ ]. These conditions can significantly impact a woman’s quality of life, leading to urinary symptoms, sexual dysfunction, and more serious complications. They also place a significant economic burden on health care systems due to costs associated with diagnosis, treatment, and management [ - ]. In contrast, there is a higher risk of severe kidney disease in men than in women [ , ]. One key factor is the higher prevalence of conditions such as diabetes and high blood pressure, which are leading causes of kidney disease [ ]. Men are more likely than women to develop these conditions, putting them at greater risk for kidney damage. Additionally, lifestyle factors such as smoking, poor diet, and lack of exercise can also contribute to the higher prevalence of end-stage kidney disease in men [ ]. Another key factor is the genetic and hormonal differences between men and women. Research has shown that certain genetic factors may predispose men to kidney disease, while hormonal differences, such as the effects of testosterone, may also influence kidney function [ ]. Understanding these biological differences is essential for developing targeted interventions to reduce the risk of different urinary system diseases [ ].As individuals age, the risk of developing urinary system diseases is more likely to increase due to a decline in urinary system function and the presence of other age-related health conditions [
, ]. Older adults face a higher risk of UTIs, stones, benign prostatic hyperplasia, and other urinary system disorders, which may lead to discomfort, urination problems, pain, and complications requiring medical treatment [ , ]. The impact of aging on urinary system diseases can result in higher health care costs and decreased quality of life, ultimately affecting overall health and well-being [ , ].According to our findings, the prevalence of urinary diseases is mainly attributable to infection. Incarcerated individuals are at a higher risk of developing UTIs due to various factors such as limited access to health care, poor hygiene practices, and overcrowded living conditions [
]. UTIs are common and can affect the bladder, kidneys, ureters, and urethra. Antimicrobial resistance is a growing concern in the treatment of UTIs. The overuse and misuse of antibiotics, along with limited access to medical resources, have contributed to the development of resistant bacteria, making it more difficult to treat these infections [ ]. UTIs pose significant challenges for individuals and health care systems regarding personal health and financial resources in the era of antimicrobial resistance [ , ].Measures to reduce the medical burden of UTIs among prisoners should include prevention, diagnosis, and treatment. Providing a healthy environment, ensuring adequate water intake, and dietary interventions such as the provision of cranberries can help reduce the incidence of UTIs [
- ]. Personal hygiene is also essential in minimizing the risk of UTIs. Regular medical screenings and access to medical care are crucial for identifying and treating UTIs in their early stages, and a well-equipped and adequately staffed health care system within correctional facilities is required to treat them [ ]. This is a multifaceted endeavor that requires a combination of education, access to resources, and comprehensive health care services. By adopting a comprehensive approach to UTI prevention—including general hygiene practices and targeted medical interventions—prisoners’ overall health and well-being can be significantly improved.Strengths
We used claims data from the NHIRD instead of prisoner questionnaires to prevent underestimation of the prevalence of urinary diseases and to avoid selection bias. The results were based on repeated diagnoses using harmonized ICD codes, minimizing measurement bias and improving the comparability of our findings.
Limitations
Our study had some limitations. First, this was a Taiwanese population-based cross-sectional study, so our findings may not be generalizable to other regions and races. Additionally, the results were based solely on claims data from the NHIRD in 2013, which could not identify any causality between the incidence of urinary diseases and imprisonment. Second, we could not obtain certain information related to urinary diseases such as socioeconomic status and biochemical factors. Furthermore, we were unable to distinguish between the duration and facility of imprisonment and criminal type to clarify the relationship between urinary diseases and imprisonment. Third, although we used data from the NHIRD instead of self-reports, the prevalence of urinary diseases is still likely to have been underestimated, as discrimination by prison officials may have prevented inmates from receiving medical services. Furthermore, the precision of diagnoses based on ICD codes can differ greatly from diseases, and ICD codes may not always accurately reflect the true clinical status, leading to potential misclassification.
Conclusions
Our study revealed sex- and age-related discrepancies in the prevalence of urinary diseases. We found that the prevalence of urinary system diseases is related to infection and inflammation. These findings emphasize the importance of diagnosis and treatment. Thus, considering these findings, comprehensive medical services that implement specialized intervention strategies or policies are needed in prisons to enhance health equality among Taiwanese prisoners and reduce their overall medical burden. Future studies should include more factors influencing health care use and the incidence of urinary diseases among prisoners to investigate ways to improve their overall quality of life and health in the prison.
Data Availability
The data used in this study are from the National Health Insurance Research Database (NHIRD), published by the Taiwan National Health Insurance (NHI) Administration. They cannot be made publicly available because of the legal restrictions imposed by the government of Taiwan concerning the "Personal Information Protection Act." The data can be made available through submitting formal proposals to the NHIRD.
Authors' Contributions
YCW, ZLJ, BLW, YPY, and THT conducted this study and drafted this paper. YCW, ZLJ, BLW, YPY, and THT participated in the design of this study and performed data synthesis. MCH assisted with revision. YCW and THT conceived this study and participated in its design and coordination. All of the authors read and approved the final paper.
Conflicts of Interest
None declared.
References
- Gatherer A. Prison health. Perspect Public Health. Nov 2009;129(6):249. [CrossRef] [Medline]
- Wildeman C, Wang EA. Mass incarceration, public health, and widening inequality in the USA. Lancet. Apr 8, 2017;389(10077):1464-1474. [CrossRef] [Medline]
- McLintock K, Sheard L. Prison healthcare in England and Wales is in perpetual crisis. BMJ. 2024;384:q562. [CrossRef]
- Cloud DH, Garcia-Grossman IR, Armstrong A, Williams B. Public health and prisons: priorities in the age of mass incarceration. Annu Rev Public Health. Apr 3, 2023;44:407-428. [CrossRef] [Medline]
- Massoglia M, Remster B. Linkages between incarceration and health. Pub Health Rep. 2019;134(1_suppl):8S-14S. [CrossRef] [Medline]
- Dumont DM, Brockmann B, Dickman S, Alexander N, Rich JD. Public health and the epidemic of incarceration. Annu Rev Public Health. Apr 2012;33:325-339. [CrossRef] [Medline]
- García-Guerrero J, Marco A. Overcrowding in prisons and its impact on health. Rev Esp Sanid Penit. Feb 2012;14(3):106-113. [CrossRef] [Medline]
- Simpson PL, Simpson M, Adily A, Grant L, Butler T. Prison cell spatial density and infectious and communicable diseases: a systematic review. BMJ Open. Jul 23, 2019;9(7):e026806. [CrossRef] [Medline]
- Watson R, Stimpson A, Hostick T. Prison health care: a review of the literature. Int J Nurs Stud. Feb 2004;41(2):119-128. [CrossRef] [Medline]
- Skarha J, Peterson M, Rich JD, Dosa D. An overlooked crisis: extreme temperature exposures in incarceration settings. Am J Public Health. Jan 2020;110(S1):S41-S42. [CrossRef] [Medline]
- Neyra JS, Davis RE. The association between climate and emergency department visits for renal and urinary disease in Charlottesville, Virginia. Environ Res. Jan 1, 2024;240(Pt 2):117525. [CrossRef] [Medline]
- Kennedy JL, Haberling DL, Huang CC, et al. Infectious disease hospitalizations: United States, 2001 to 2014. Chest. Aug 2019;156(2):255-268. [CrossRef] [Medline]
- Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. Dec 2010;7(12):653-660. [CrossRef] [Medline]
- Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. Nov 2020;38(11):2669-2679. [CrossRef] [Medline]
- Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health. 2022;10:888205. [CrossRef] [Medline]
- Zeng Z, Zhan J, Zhang K, Chen H, Cheng S. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol. Mar 2022;40(3):755-763. [CrossRef] [Medline]
- Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. Nov 2010;122(6):7-15. [CrossRef] [Medline]
- Sakoi N, Mori Y, Tsugawa Y, Tanaka J, Fukuma S. Early-stage chronic kidney disease and related health care spending. JAMA Netw Open. Jan 2, 2024;7(1):e2351518. [CrossRef] [Medline]
- Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol. Jan 2024;20(1):7-20. [CrossRef] [Medline]
- de Menezes PR, Vasconcelos CTM, Lopes LG, de Almeida MEM, Castro RCMB, Neto JAV. Lower urinary tract symptoms in female prison inmates: prevalence and impact on quality of life. Int Urogynecol J. Oct 2021;32(10):2795-2802. [CrossRef] [Medline]
- Murphy M, Ding A, Berk J, Rich J, Bayliss G. Kidney disease among people who are incarcerated. Clin J Am Soc Nephrol. Nov 2021;16(11):1766-1772. [CrossRef] [Medline]
- Yang YP, Hsin HT, Wang BL, et al. Gender differences in oral health among prisoners: a cross-sectional study from Taiwan. BMC Oral Health. Nov 21, 2023;23(1):900. [CrossRef] [Medline]
- Tsai CY, Jiesisibieke ZL, Tao P, et al. Prevalence of eye and adnexal disorders among elderly inmates in Taiwan prisons. BMC Public Health. Jan 31, 2024;24(1):334. [CrossRef] [Medline]
- Shih YJ, Wang JY, Wang YH, Shih RR, Yang YJ. Analyses and identification of ICD codes for dementias in the research based on the NHIRD: a scoping review protocol. BMJ Open. Aug 10, 2022;12(8):e062654. [CrossRef] [Medline]
- Jiesisibieke ZL, Yang YP, Wang YC, Chien CW, Tung TH. Prevalence of skin diseases among elderly prisoners in Taiwan: an examination of skin health in prison. BMC Geriatr. Jul 6, 2024;24(1):583. [CrossRef] [Medline]
- ICD-9-CM official guidelines for coding and reporting. CDC. URL: https://stacks.cdc.gov/view/cdc/140851 [Accessed 2024-11-15]
- National health insurance medical annual statistical Ministry of Health and Welfare, Taiwan. Ministry of Health and Welfare. URL: https://dep.mohw.gov.tw/dos/lp-5103-113-xCat-y102.html [Accessed 2024-11-15]
- Tsai MH, Hsu CY, Lin MY, et al. Incidence, prevalence, and duration of chronic kidney disease in Taiwan: results from a community-based screening program of 106,094 individuals. Nephron. 2018;140(3):175-184. [CrossRef] [Medline]
- Conte C, Antonelli G, Melica ME, Tarocchi M, Romagnani P, Peired AJ. Role of sex hormones in prevalent kidney diseases. Int J Mol Sci. May 4, 2023;24(9):8244. [CrossRef] [Medline]
- Deltourbe L, Lacerda Mariano L, Hreha TN, Hunstad DA, Ingersoll MA. The impact of biological sex on diseases of the urinary tract. Mucosal Immunol. May 2022;15(5):857-866. [CrossRef] [Medline]
- Cox S, Nasseri R, Rubin RS, Santiago-Lastra Y. Genitourinary syndrome of menopause. Med Clin North Am. Mar 2023;107(2):357-369. [CrossRef] [Medline]
- Ansaldi Y, de Tejada Weber BM. Urinary tract infections in pregnancy. Clin Microbiol Infect. Oct 2023;29(10):1249-1253. [CrossRef] [Medline]
- Gabriel I, Vitonis AF, Missmer SA, et al. Association between endometriosis and lower urinary tract symptoms. Fertil Steril. Apr 2022;117(4):822-830. [CrossRef] [Medline]
- Wang X, Jin Y, Xu P, Feng S. Urinary incontinence in pregnant women and its impact on health-related quality of life. Health Qual Life Outcomes. Jan 21, 2022;20(1):13. [CrossRef] [Medline]
- Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. Jul 6, 2017;3:17042. [CrossRef] [Medline]
- Grigoryan L, Mulgirigama A, Powell M, Schmiemann G. The emotional impact of urinary tract infections in women: a qualitative analysis. BMC Womens Health. May 18, 2022;22(1):182. [CrossRef] [Medline]
- Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. [CrossRef] [Medline]
- Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. Feb 2003;49(2):53-70. [CrossRef] [Medline]
- Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharmacoecon Outcomes Res. Feb 2018;18(1):107-117. [CrossRef] [Medline]
- Swartling O, Rydell H, Stendahl M, Segelmark M, Trolle Lagerros Y, Evans M. CKD progression and mortality among men and women: a nationwide study in Sweden. Am J Kidney Dis. Aug 2021;78(2):190-199. [CrossRef] [Medline]
- Hecking M, Hödlmoser S, Ahmed SB, Carrero JJ. The other way around: living with chronic kidney disease from the perspective of men. Semin Nephrol. Mar 2022;42(2):122-128. [CrossRef] [Medline]
- Khan J, Shaw S. Risk of multiple lower and upper urinary tract problems among male older adults with type-2 diabetes: a population-based study. Aging Male. Dec 2023;26(1):2208658. [CrossRef] [Medline]
- Li D, Xu J, Liu F, Wang X, Yang H, Li X. Alcohol drinking and the risk of chronic kidney damage: a meta-analysis of 15 prospective cohort studies. Alcohol Clin Exp Res. Jul 2019;43(7):1360-1372. [CrossRef] [Medline]
- Zhao JV, Schooling CM. The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Biobank. BMC Med. Jun 4, 2020;18(1):122. [CrossRef] [Medline]
- Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci (Lond). Jul 1, 2016;130(14):1147-1163. [CrossRef] [Medline]
- Ortiz A, Mattace-Raso F, Soler MJ, Fouque D. Ageing meets kidney disease. Nephrol Dial Transplant. Feb 28, 2023;38(3):523-526. [CrossRef]
- Khosla L, Gong S, Weiss JP, Birder LA. Oxidative stress biomarkers in age-related lower urinary tract disorders: a systematic review. Int Neurourol J. Mar 2022;26(1):3-19. [CrossRef] [Medline]
- Cannarella R, Condorelli RA, Barbagallo F, La Vignera S, Calogero AE. Endocrinology of the aging prostate: current concepts. Front Endocrinol (Lausanne). 2021;12:554078. [CrossRef] [Medline]
- Lee MJ, Ha KH, Kim DJ, Park I. Trends in the incidence, prevalence, and mortality of end-stage kidney disease in South Korea. Diabetes Metab J. Dec 2020;44(6):933-937. [CrossRef] [Medline]
- Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen CI, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. Jan 2014;65(1):79-95. [CrossRef] [Medline]
- Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990-2013. Eur Urol. Mar 2017;71(3):437-446. [CrossRef] [Medline]
- Carvalho SGD, Santos ABSD, Santos IM. The pandemic in prison: interventions and overisolation. Cien Saude Colet. Sep 2020;25(9):3493-3502. [CrossRef] [Medline]
- Salm J, Salm F, Arendarski P, Kramer TS. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Euro Surveill. Jul 2022;27(30):2101012. [CrossRef] [Medline]
- Pothoven R. Management of urinary tract infections in the era of antimicrobial resistance. Drug Target Insights. 2023;17:126-137. [CrossRef] [Medline]
- Burrows LL. It’s uncomplicated: prevention of urinary tract infections in an era of increasing antibiotic resistance. PLoS Pathog. Feb 2024;20(2):e1011930. [CrossRef] [Medline]
- Zemdegs J, Iroz A, Vecchio M, Roze S, Lotan Y. Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries. BMC Health Serv Res. Nov 3, 2023;23(1):1197. [CrossRef] [Medline]
- Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. Apr 17, 2023;4(4):CD001321. [CrossRef] [Medline]
- Von Vietinghoff S, Shevchuk O, Dobrindt U, et al. The global burden of antimicrobial resistance – urinary tract infections. Nephrol Dial Transplant. Mar 27, 2024;39(4):581-588. [CrossRef]
- Tsiakoulias E, Gravas S, Hadjichristodoulou C, et al. Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis. World J Urol. Jan 12, 2024;42(1):27. [CrossRef] [Medline]
- Hou PJ, Lin PY, Lin WL, Hsueh TP. Integrated traditional herbal medicine for recurrent urinary tract infection treatment and follow-up: a meta-analysis of randomized controlled trials. J Ethnopharmacol. Mar 1, 2024;321:117491. [CrossRef] [Medline]
- Fanshawe TR, Judge RK, Mort S, Butler CC, Hayward GN. Evidence-based appraisal of two guidelines for the diagnosis of suspected, uncomplicated urinary tract infections in primary care: a diagnostic accuracy validation study. J Antimicrob Chemother. Aug 2, 2023;78(8):2080-2088. [CrossRef] [Medline]
Abbreviations
CKD: chronic kidney disease |
ICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification |
NHIRD: National Health Insurance Research Database |
UTI: urinary tract infection |
Edited by Amaryllis Mavragani; submitted 02.05.24; peer-reviewed by Meng-Sui Lee, Pi-Ching Yu; final revised version received 02.10.24; accepted 09.10.24; published 24.12.24.
Copyright© Yen-Chun Wang, Zhu Liduzi Jiesisibieke, Yu‑Pei Yang, Bing‑Long Wang, Ming-Chon Hsiung, Tao-Hsin Tung. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 24.12.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.